Physician profile
Tracy Bartel
NPI 1063979953
$2,268.94
in general payments reported to CMS, 2019-2025
14 companies · $1,336 in 2025
The $1,336 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $574 · 2022: $59.79 · 2023: $150 · 2024: $148 · 2025: $1,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,132 · Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,131.55 |
| Food and Beverage | $503.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,349.38 | 2024-2025 | |
| Abbott Laboratories | $542.17 | 2021 | |
| Baxter Healthcare | $90.99 | 2022-2025 | Floseal |
| Integra Lifesciences Corporation | $55.20 | 2024 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Astrazeneca Pharmaceuticals LP | $34.35 | 2022-2023 | Andexxa |
| Alexion Pharmaceuticals, INC. | $29.90 | 2021-2022 | |
| Sk Life Science, INC. | $29.05 | 2023 | |
| Biocomposites INC | $24.05 | 2025 | Stimulan |
| Servier Pharmaceuticals LLC | $21.52 | 2024 | |
| Tanabe Pharma America, INC. | $20.01 | 2023 | |
| Eisai INC. | $19.87 | 2023 | |
| Kls-Martin L.P. | $19.02 | 2021 | |
| Argenx US, INC. | $18.81 | 2023 | Vyvgart |
| Lilly USA, LLC | $14.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Bartel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.